Measuring Impact
Since its inception, the CQI portfolio has implemented numerous quality improvement initiatives aimed at improving health care and lowering costs across the state of Michigan. The Michigan Value Collaborative (MVC) partners with individual CQIs to measure the impact and value of those initiatives to ensure CQIs are using resources effectively.
MVC's data-driven evaluations of CQI efforts reveal significant improvements to healthcare outcomes and substantial cost savings across a wide variety of clinical areas. Learn more about the specific findings, methodologies, and opportunities for next steps in the value assessments below.
Impact and Value Assessments
ASPIRE: Payment Avoidance Project
The ASPIRE report highlights significant improvements in organizational performance, quality of care, and cost efficiencies across participating healthcare institutions. Using a data-driven approach, the findings underscore that ASPIRE initiatives led to measurable enhancements in patient outcomes and resource utilization, affirming the program's value for stakeholders. Participating in an anesthesia CQI is associated with lower costs for health systems with common surgical procedures.
BMC2: Cardiac Rehabilitation after Percutaneous Coronary Intervention (PCI)
BMC2 participation results in substantial financial savings and significant improvements in clinical outcomes for participating sites. The findings from this report demonstrate that the program effectively reduces complications and readmission rates for PCI patients, providing value both economically and in quality of patient care. BMC2 led cardiac rehabilitation referrals avoided 145 readmissions, equating to approximately $1.8 million healthcare dollars saved.
MBSC: Opioid Spending After Bariatric Surgery
MBSC continues to have a positive impact on prescribing practices and patient outcomes across participating surgical centers. By implementing evidence-based guidelines and tracking opioid use, the initiative has helped reduce unnecessary prescriptions and improve post-surgical recovery, resulting in both clinical and operational benefits for providers and patients, resulting in a savings of $12.5 million in opioid prescription spending.
MOQC: Antiemetic Use in Patients Receiving Chemotherapy
The MOQC value report highlights the program’s achievements in enhancing the quality of oncology care and increasing operational efficiencies across participating practices, particularly in the treatment of chemotherapy induced nausea and vomiting (CINV). MOQC anti-nausea medication prescribing guidelines have led to improved patient outcomes, with patients who are receiving chemotherapy at MOQC practices with high-prescribing rates of antiemetics, visiting the ED and being readmitted to the hospital less, saving an estimated $334,095.
MSQC: Colectomy Post-Discharge Savings
Through data-driven interventions and shared best practices, MSQC initiatives have contributed to reductions in surgical complications and improved operational performance, helping hospitals save $3 Million in colectomy post-discharge spending.
MSSIC: Direct and Indirect Savings for Spine Surgery
MSSIC strives to improve the quality and safety of spine surgery care across participating hospitals. MSSIC participation adds significant value through enhanced clinical practices and cost savings in spine surgery care, with MSSIC participating health centers saving an estimated $16,490,726 from prevented readmissions and prevented events of urinary retention.
MUSIC: Opioid Spending After Kidney Stone Surgery
The MUSIC ROCKS program, aimed at improving the quality of care for kidney stone patients, has contributed to better patient outcomes and lower opioid prescribing among participating sites. MUSIC providers averted $4.8 Million in avoided opioid prescription spending after kidney stone surgery, without sacrificing patient comfort or care quality.
MUSIC: Opioid Spending After Prostate Surgery
The MUSIC Prostate Team aims to optimize opioid prescribing practices following prostatectomy procedures across participating institutions. By implementing evidence-based guidelines and monitoring prescription patterns, the initiative has helped reduce unnecessary opioid use while supporting improved patient recovery, averting $1.6 Million in avoided opioid prescription spending after prostate surgery.
About the Value Partnerships
The CQIs are a part of the Value Partnerships, a group of clinical quality improvement programs connecting Blue Cross, doctors, and hospitals across Michigan to improve health care for everyone. By working together and sharing data and best practices, these programs help health professionals deliver better outcomes for their patients through a value-based, outcomes-focused approach.
Since 2005, Value Partnerships has moved away from the old fee-for-service model and instead rewards providers for successfully managing patient health. This shift has saved $6.3 billion by reducing unnecessary tests, complications, ER visits, and hospital stays, while improving care coordination and quality across a wide range of hospital and outpatient settings. Learn more about the Value Partnerships and the over twenty years of collaboration and innovation the program has fostered-visit their website now.